Published in Psychosom Med on December 29, 1999
The challenge of patient adherence. Ther Clin Risk Manag (2005) 2.72
Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med (2006) 2.55
Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord (2006) 1.35
Adherence to treatment of osteoporosis: a need for study. Osteoporos Int (2007) 1.13
Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart (2004) 1.12
Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians. Can Fam Physician (2009) 1.12
Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction. J Gen Intern Med (2010) 1.08
Relationship between non-specific prescription pill adherence and ischemic stroke outcomes. Cerebrovasc Dis (2009) 0.95
The evolution of transdermal/topical overactive bladder therapy and its benefits over oral therapy. Rev Urol (2009) 0.84
Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST). Contemp Clin Trials (2012) 0.84
Towards personalizing treatment for depression : developing treatment values markers. Patient (2013) 0.83
Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. Am J Med (2012) 0.77
Depression in patients with heart disease: the case for more trials. Future Cardiol (2010) 0.77
The evolution of transdermal/ topical overactive bladder therapy and its benefits over oral therapy. Rev Obstet Gynecol (2009) 0.77
The effect of placebo adherence on reducing cardiovascular mortality: a meta-analysis. Clin Res Cardiol (2013) 0.75
Depression and poor adherence to lipid-lowering medications among patients with coronary artery disease. J Psychosom Res (2010) 0.75
The Ensembl genome database project. Nucleic Acids Res (2002) 40.87
Ensembl 2009. Nucleic Acids Res (2008) 25.38
Ensembl 2008. Nucleic Acids Res (2007) 20.67
Ensembl 2007. Nucleic Acids Res (2006) 20.10
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
The Burlington randomized trial of the nurse practitioner. N Engl J Med (1974) 17.02
Ensembl 2005. Nucleic Acids Res (2005) 15.13
A controlled trial of teaching critical appraisal of the clinical literature to medical students. JAMA (1987) 14.20
Isolation of an E. coli strain with a mutation affecting DNA polymerase. Nature (1969) 12.96
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA (1999) 12.75
Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res (2003) 12.26
Ensembl 2004. Nucleic Acids Res (2004) 11.88
Ensembl 2006. Nucleic Acids Res (2006) 11.66
Mutation selection and the natural history of cancer. Nature (1975) 9.73
Controversy in counting and attributing events in clinical trials. N Engl J Med (1979) 7.25
The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor. Cell (1994) 6.88
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med (1995) 6.86
Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol (2001) 6.68
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol (1991) 6.55
Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol (2000) 6.46
RANK is essential for osteoclast and lymph node development. Genes Dev (1999) 5.85
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis (1994) 5.44
Redesigning health care. BMJ (2001) 5.43
A new pathway for DNA repair in Escherichia coli. Nature (1977) 5.37
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood (2000) 5.06
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res (1996) 4.75
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med (1996) 4.70
Identification of a genetic locus for familial atrial fibrillation. N Engl J Med (1997) 4.66
Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ (2001) 4.50
Determining optimal therapy--randomized trials in individual patients. N Engl J Med (1986) 4.49
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med (2001) 4.46
The Burlington randomized trial of the nurse practitioner: health outcomes of patients. Ann Intern Med (1974) 4.37
Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med (1998) 4.29
Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature (1984) 4.28
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol (1994) 4.27
Synthesis of the yeast cell wall and its regulation. Annu Rev Biochem (1982) 4.26
TB policy and the badger culling trials. Vet Rec (2006) 4.14
Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med (2000) 4.14
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Do sick newborn infants benefit from participation in a randomized clinical trial? J Pediatr (1999) 3.98
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med (2003) 3.94
The clinical and laboratory diagnosis of Trichomonas vaginalis infection. Sex Transm Dis (1981) 3.89
TB policy and the badger culling trials. Vet Rec (2006) 3.84
The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry (1990) 3.75
Systematic review of multidisciplinary interventions in heart failure. Heart (2005) 3.68
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med (1993) 3.67
Comparison of percutaneous and surgical tracheostomies. Chest (1996) 3.56
Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol (2001) 3.53
The "redisorganisation" of the NHS. BMJ (2001) 3.52
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet (1994) 3.51
Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet (2000) 3.50
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science (1984) 3.47
Effect of low-level body burdens of lead on the mental development of children: limitations of meta-analysis in a review of longitudinal data. Arch Environ Health (1992) 3.42
WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell Mol Life Sci (2001) 3.38
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res (1989) 3.35
A clinician's guide for conducting randomized trials in individual patients. CMAJ (1988) 3.35
Effect of bromhexine on ventilatory capacity in patients with a variety of chest diseases. Lancet (1969) 3.34
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation (2001) 3.33
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med (2000) 3.32
Verifying quality and safety in health informatics services. BMJ (2001) 3.31
The future of advanced practice psychiatric nursing. Perspect Psychiatr Care (2004) 3.30
Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect (2004) 3.27
The origin of human cancers. Nature (1981) 3.24
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation (2001) 3.21
Cervical screening in Perth and Kinross since introduction of the new contract. BMJ (1991) 3.20
Mutations in the lactose operon caused by bacteriophage Mu. J Mol Biol (1972) 3.17
A low resolution structure for the histone core of the nucleosome. Nature (1980) 3.17
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med (1982) 3.16
The segregation of DNA in epithelial stem cells. Cell (1978) 3.12
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg (1995) 3.08
Public health gets a boost in NHS streamlining. BMJ (1994) 3.03
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med (1985) 2.99
WEIL'S DISEASE (LEPTOSPIROSIS): A CLINICAL AND BACTERIOLOGICAL STUDY OF NINETEEN CASES OCCURRING CHIEFLY AMONG FISH WORKERS. Br Med J (1934) 2.99
The dynamics of chromosome evolution in birds and mammals. Nature (1999) 2.95
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology (1994) 2.95
Mechanisms of directed mutation. Genetics (1992) 2.92
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med (1979) 2.91
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr (1983) 2.89
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Women prefer hospital births. BMJ (1992) 2.88
Significance testing to establish equivalence between treatments, with special reference to data in the form of 2X2 tables. Biometrics (1977) 2.87
Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys (1994) 2.86
Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol (1982) 2.84
The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol (2001) 2.83